The city of Rochester, Minnesota, currently has 7 active clinical trials seeking participants for Ulcerative Colitis research studies.
Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis
Recruiting
The goal of this study is to learn if tilpisertib fosmecarbil (formerly known as GS-5290) is effective and safe in treating participants with moderate to severe ulcerative colitis. The study will compare participants in different treatment groups treated with tilpisertib fosmecarbil with participants treated with placebo. The primary objective of this study is to demonstrate the efficacy of tilpisertib fosmecarbil, compared to placebo control, in achieving Clinical Response at Week 12.
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
05/03/2024
Locations: Mayo Clinic, Rochester, Minnesota
Conditions: Ulcerative Colitis
Hyperbaric Oxygen Therapy for Ulcerative Colitis
Recruiting
Chronic intestinal hypoxia and accompanying mucosal inflammation is a hallmark of ulcerative colitis (UC). Hyperbaric oxygen therapy (HBOT) involves breathing 100% oxygen under increased atmospheric pressure to increase tissue oxygenation. Two small prospective randomized controlled trials have demonstrated that the delivery of HBOT to UC patients hospitalized for acute moderate to severe flares results in improved remission rates and avoidance of in-hospital progression to biologics, small mole... Read More
Gender:
All
Ages:
Between 18 years and 85 years
Trial Updated:
04/12/2024
Locations: Mayo Clinic, Rochester, Minnesota
Conditions: Ulcerative Colitis
VE202 in Patients With Mild-to-Moderate Ulcerative Colitis
Recruiting
A Phase 2 study to evaluate the safety, efficacy, and microbiota changes of VE202 in patients with mild to moderate ulcerative colitis (UC).
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
03/29/2024
Locations: Mayo Clinic, Rochester, Minnesota
Conditions: Ulcerative Colitis, Colitis, Ulcerative
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Recruiting
The study is an extension of two parent studies (MLN0002-3024 [NCT04779307] and MLN0002-3025 [NCT04779320]). Participants must have participated in one of the previous studies. The purpose of this study is to collect the long-term safety of vedolizumab in children with UC or CD.
Gender:
All
Ages:
2 years and above
Trial Updated:
03/05/2024
Locations: Mayo Clinic - PIN, Rochester, Minnesota
Conditions: Ulcerative Colitis, Crohn's Disease
R-3750 in Patients With Mild to Moderate Ulcerative Colitis
Recruiting
The goal of this study is to determine the safety and tolerability of orally taken probiotic (R-3750) in patients with mild to moderate ulcerative colitis. Patients will take an oral dosage of probiotic (R-3750) and provide patient-reported and physician scored measures of their colitis. Blood and fecal evaluations of inflammation and assessment of probiotic (R-3750) on fecal levels will also be measured.
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
10/31/2023
Locations: Mayo Clinic, Rochester, Minnesota
Conditions: Ulcerative Colitis Chronic Mild, Ulcerative Colitis Chronic Moderate, Ulcerative Colitis Chronic, Ulcerative Colitis
A Study of Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative Colitis
Recruiting
The purpose of this research is to gather information on the safety and effectiveness of Endoscopic Sleeve Gastroplasty (ESG) for weight loss in a population of obese ulcerative colitis (UC) patients undergoing colectomy with eventual Ileal Pouch Anal Anastomosis (IPAA) compared to counseling on diet and lifestyle interventions alone.
Gender:
All
Ages:
Between 22 years and 69 years
Trial Updated:
10/18/2023
Locations: Mayo Clinic Minnesota, Rochester, Minnesota
Conditions: Obesity, Ulcerative Colitis
Angiographic Delivery of AD-MSC for Ulcerative Colitis
Recruiting
Researchers are trying to determine the safety and feasibility of using an adipose derived mesenchymal stem cell (MSC) to treat people with Ulcerative Colitis.
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
10/02/2023
Locations: Mayo Clinic in Rochester, Rochester, Minnesota
Conditions: Ulcerative Colitis